Vivli
Vivli is an independent non-profit operating a secure cloud-based clinical research data sharing platform on Microsoft Azure, holding 8,000+ trials and 5.2 million participants. It serves pharmaceutical companies, academic researchers, and government funders as a neutral broker for secondary clinical trial data analysis.
- Company typePrivate
- Founded2017
- HeadquartersCambridge, United States
- Headcount1–10
- GTM typeB2B
- OfferingSoftware
What Vivli does
Vivli is an independent non-profit organization that operates a global clinical research data sharing platform, functioning as a neutral broker between pharmaceutical and biotech companies that contribute individual-participant-level clinical trial data and academic, government, and clinical researchers who request access for secondary analyses. Founded in 2013 and headquartered in Cambridge, Massachusetts, Vivli maintains a repository of more than 8,000 clinical trials covering approximately 5.2 million participants and reports 530+ publications generated from platform-mediated research. The organization serves customers that include large pharmaceutical companies (Pfizer, AbbVie, Roche, UCB, GSK, Sanofi, Boehringer Ingelheim, Alnylam), academic institutions (Harvard University), federal research programs (NIH HEAL Initiative), and disease-focused non-profits (CureDuchenne, Critical Path Institute's RDCA-DAP).
The core technology is a cloud-based platform hosted on Microsoft Azure (with Media Temple for web hosting) that combines an independent data repository, an in-depth search engine, and a Secure Research Environment (SRE) for approved analyses. Access control follows the Five Safes Framework (Safe People, Safe Projects, Safe Data, Safe Settings, Safe Outputs), and a proprietary three-stage data anonymization pipeline transforms source data through pseudonymization to fully anonymized datasets using age banding, date shifting, and sensitive-narrative redaction. The platform has been extended with specialized portals: the Vivli AMR Register for antimicrobial resistance surveillance (launched 2022 with Wellcome Trust funding) and the HIV/AIDS Portal (launched 2023 with NIH Office of AIDS Research funding). Version 4.0, released June 27, 2026, introduced redesigned navigation and platform-wide Multi-Factor Authentication.
Vivli operates a membership-based business model in which pharmaceutical companies, academic institutions, and research organizations pay subscription-style membership fees plus managed-service fees for data sharing and access. Pricing is not publicly disclosed and is negotiated quote-based. The organization is funded through a combination of member fees, data contributor fees, and grants from federal and charitable funders including the NIH HEAL Initiative and Wellcome Trust, rather than through venture capital or private equity. Vivli has established Vivli Europe, a separate European non-profit entity headquartered in Amsterdam, to serve data holders needing to comply with the European Health Data Space secondary-use requirements.
Vivli firmographics
Firmographics- Name
- Vivli
- Legal name
- Vivli Inc.
- Website
- https://vivli.org
- Company type
- Private
- Founded year
- 2017
- Operating status
- Operating
- Headcount range
- 1–10 employees
- Short description
- Vivli is an independent non-profit operating a secure cloud-based clinical research data sharing platform on Microsoft Azure, holding 8,000+ trials and 5.2 million participants. It serves pharmaceutical companies, academic researchers, and government funders as a neutral broker for secondary clinical trial data analysis.
- Ownership category
- akta.pro rank
Vivli industry classification
Industry- Product category
- Clinical Research Data Sharing
- NAICS
- Software Publishers (513210), Computer Systems Design and Related Services (54151)
- SIC
- Services-Computer Processing & Data Preparation (7374), Services-Prepackaged Software (7372)
- akta.pro primary industry
- Site Data Management Support (EDC/Source/SDV Readiness) (HLAGACAL)
- akta.pro secondary industry
- Data Loss Prevention (DLP) & Sensitive Data Discovery (PHI/PII) (HLACAJAC)
Keywords
Where Vivli is headquartered
LocationHeadquarters
- HQ city
- Cambridge
- HQ country
- United States
- HQ region
- North America
Offices2 records
Markets served
Vivli business model
Business model- GTM type
- B2B
- Offering type
- Software
- Cost components
- Personnel, Technology or R&D, Infrastructure, Operations, Marketing or Sales
Revenue model
- Membership Fees: Vivli operates as a non-profit organization with pharmaceutical companies, academic institutions, and research organizations as member organizations. Members pay fees to join and gain access to share and request clinical trial data through the platform.
- Research Platform Services: Provides secure research environment and data sharing infrastructure services to members for secondary analysis of clinical trial data
Go-to-market motion3 records
Distribution channels4 records
Marketing channels6 records
Vivli product offering
Product offeringCore offering
Vivli operates a global clinical research data sharing platform consisting of an independent data repository, a search engine, and a secure research environment (SRE) where researchers can request, access, and analyze participant-level data from completed clinical trials. The platform also includes specialized portals for antimicrobial resistance (AMR) surveillance and HIV/AIDS trial data, and offers data anonymization services to transform source data into shareable datasets.
Product overview
Vivli operates a unified data sharing platform ecosystem comprising the main Vivli Platform (a global clinical research data sharing platform with an independent data repository, in-depth search engine, and secure research environment), supported by specialized thematic portals including the Vivli AMR Register for antimicrobial resistance surveillance data and the HIV/AIDS Portal for HIV clinical trial data. The organization also includes Vivli Europe, a separate European entity established to help data holders comply with Europe's secondary-use of health data requirements. The platform facilitates sharing and reuse of individual participant-level data from completed clinical trials, serving as a neutral broker between data contributors, data users, and the wider data sharing community.
Differentiator
Problem solved
Functional benefit
Brands
- Vivli AMR: A global AMR surveillance data sharing platform dedicated to helping industry share antimicrobial resistance surveillance data with researchers.
- Vivli HIV/AIDS Portal
Products and services
- Vivli Platform A global clinical research data sharing platform that includes an independent data repository with 8,000+ clinical trials, an in-depth search engine, and a secure research environment (SRE) enabling approved researchers to request, access, and analyze participant-level data from completed clinical trials.
- Vivli AMR Register A global antimicrobial resistance (AMR) surveillance data sharing platform that helps industry share AMR surveillance data with researchers in the fight against antimicrobial resistance.
- HIV/AIDS Portal A specialized portal for sharing and accessing completed HIV/AIDS clinical trial data, funded by NIH Office of AIDS Research.
- Vivli Europe An independent European non-profit organization established in Amsterdam to help data holders meet Europe's secondary-use of health data requirements and unlock the value of clinical research data responsibly.
Quantifiable outcome
- 530+ peer-reviewed publications generated from research using Vivli platform data
- +3 more outcomes
Companies that use Vivli
Customer profileNamed customers8 records
Segments5 records
Ideal customer profiles3 records
Vivli technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature6 records
Vivli partnerships and signals
Strategic signalPartnerships
Twelve partnerships are on record, tiered core and major.
- Critical Path Institute (C-Path) - RDCA-DAPcorePartnership between Vivli and Critical Path Institute's Rare Disease Cures Accelerator Data and Analytics Platform (RDCA-DAP) to share rare disease data responsibly while protecting patient privacy. In a 2025 webinar, COO Julie Wood discussed the partnership to advance rare disease research through coordinated data sharing.
- NIH HEAL InitiativecoreNIH HEAL designated Vivli as its recommended repository for data sharing from HEAL-funded research on opioid crisis and chronic pain. Vivli platform linked to NIH HEAL Data Platform via DOIs for bi-directional findability.
- PfizermajorPfizer is a member organization sharing clinical trial data through the Vivli platform. Pfizer has also participated in the AMR Data Challenge as a data contributor.
- RochemajorRoche is a member organization sharing clinical trial data. Quote from Global Biometrics Head Jeff Helterbrand welcomes working with Vivli as a trusted partner during public health challenges.
- AbbViemajorAbbVie is a member organization contributing clinical trial data to the Vivli platform for secondary research use.
- UCBmajorUCB is a member organization supporting Vivli's work to drive collaboration and data sharing. Chief Medical Officer Professor Dr. Iris Loew-Friedrich cited belief that data sharing will enhance disease understanding and help develop new treatments.
- Harvard UniversitymajorHarvard University is an academic member supporting Vivli. Chief Research Compliance Officer Ara Tahmassian stated Vivli's mission is fully aligned with Harvard's promoting collaborative research and data sharing transparency.
- GSK (GlaxoSmithKline)majorGSK is a member organization sharing clinical trial data through Vivli. Contributed Harmony Outcomes study data enabling cardiovascular outcomes research in Type 2 Diabetes.
- SanofimajorSanofi is a member and data contributor to Vivli. Contributed data to the PANTHER collaborative initiative for cardiovascular research.
- Boehringer IngelheimmajorBoehringer Ingelheim is a member organization working with Vivli on image anonymization best practices as part of a multi-company partnership including Biogen, Pfizer, and Sanofi.
- Microsoft AzurecoreMicrosoft Azure provides cloud hosting for Vivli's website and platform. Microsoft has access to personal data collected through the platform per their privacy statement.
- Media TemplecoreMedia Temple provides website hosting services for Vivli's online platforms.
Scale indicators8 records
Recent moves7 records
Expansion highlights5 records
Vivli competitors and assessment
Company assessmentDirect peers
- BioLINCC (NHLBI Biorepository): NIH-funded clinical trial data and biospecimen repository from NHLBI-sponsored studies. Comparable as a public-sector alternative with similar dataset discovery and request workflows.
- ClinicalStudyDataRequest.com (CSDR): Multi-sponsor clinical trial data sharing platform backed by major pharma companies. Most direct competitor to Vivli, offering request-and-access workflows for participant-level data with similar anonymization and governance models.
- Supporting Open Access for Researchers (SOAR): Duke Clinical Research Institute's clinical trial data sharing platform. Offers similar request-based access to industry-contributed participant-level data for academic researchers.
- Yale University Open Data Access (YODA) Project: Academic-hosted clinical data sharing platform originally built for Medtronic device data, now serving multiple sponsors. Closely comparable model to Vivli with a neutral broker and external review panel.
- Project Data Sphere: Oncology-focused clinical trial data sharing platform with comparable model to Vivli's specialized portals. Operates as a neutral broker for industry-contributed cancer trial data.
Emerging players
- OpenClinica: Clinical trial data capture and eClinical platform. Comparable in serving the clinical trial data lifecycle, though focused more on primary data capture than secondary-use sharing.
- The Hyve: Open-source clinical and translational research data platform vendor based in the Netherlands. Comparable as a specialized clinical research data infrastructure provider serving pharma and academic consortia.
- Dryad: General-purpose research data repository with a curation and publication model. Comparable in operating a hosted data sharing service with member/publisher fee structure, though broader than clinical trials.
Broad incumbents
- TriNetX: Large-scale clinical research network and real-world data platform used by pharma for trial feasibility and observational research. Comparable in serving pharma's secondary clinical data needs, though focused on real-world data rather than completed trial participant-level data.
Others
- TransCelerate BioPharma: Pharma consortium developing shared clinical trial infrastructure and data sharing standards. Comparable as an industry-level ecosystem player influencing how pharma members approach data sharing, though not a direct platform competitor.
Market position
Strengths4 records
Weaknesses4 records
Competitive moat5 records
Key risks5 records
Key highlights6 records
Customer concentration
Vivli social profiles
Digital presenceVivli financial estimates
Financial estimateRevenue estimate
Valuation estimate
Vivli leadership team
Management profileNumber of profiles
Profiles6 records
Vivli subsidiaries and ownership
Company hierarchySubsidiaries1 record
Vivli funding detail
Funding detailFunding overview
Funding rounds
Investors
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Vivli M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Vivli
What does Vivli do?
Vivli operates a global clinical research data sharing platform consisting of an independent data repository, a search engine, and a secure research environment (SRE) where researchers can request, access, and analyze participant-level data from completed clinical trials. The platform also includes specialized portals for antimicrobial resistance (AMR) surveillance and HIV/AIDS trial data, and offers data anonymization services to transform source data into shareable datasets.
Is Vivli a public or private company?
Vivli is a private company. It is classified as nonprofit foundation owned and is currently operating.
When was Vivli founded?
Vivli was founded in 2017. It employs 1 to 10 people.
Where is Vivli based?
Vivli is headquartered in Cambridge, United States, in the North America region.
How does Vivli make money?
Two revenue lines are on record. Membership Fees are the primary driver. The others are research Platform Services.
Who are Vivli's main competitors?
Direct peers on record are BioLINCC (NHLBI Biorepository), ClinicalStudyDataRequest.com (CSDR), Supporting Open Access for Researchers (SOAR), Yale University Open Data Access (YODA) Project and Project Data Sphere. Emerging players are OpenClinica, The Hyve and Dryad. TriNetX is listed as a broad incumbent. TransCelerate BioPharma is listed as an others.
Does Vivli have an API?
No public API is recorded for Vivli.
What industry is Vivli in?
Vivli's product category is Clinical Research Data Sharing. Its primary akta.pro industry code is HLAGACAL, Site Data Management Support (EDC/Source/SDV Readiness), with a secondary code of HLACAJAC, Data Loss Prevention (DLP) & Sensitive Data Discovery (PHI/PII). Its NAICS code is 513210 and its SIC code is 7374.